April 25th 2025
When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Older Adults in Traditional Medicare Spend Weeks Per Year on Health Care Contact Days
February 1st 2024Days spent obtaining health care outside the home may show access to needed care, but also add up to substantial time, effort, and cost burdens to patients and those who care for them, according to the study authors.
Read More
CMS released the proposed 2025 Advance Notice for the Medicare Advantage (MA) and Medicare Part D Prescription Drug Programs; there have been 561 deaths related to the use of Philips’ recalled ventilators and machines for treating obstructive sleep apnea since 2021; the FDA warned the public against copycat eye drops due to infection risk.
Read More
40-GEP Test Utilization Can Mitigate Financial Burden of Cutaneous Squamous Cell Carcinoma
February 1st 2024Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions.
Read More
Translating DMD Clinical Trial Findings to Real-World Application Discouraging
January 31st 2024This analysis compared outcomes among patients who have Duchenne muscular dystrophy (DMD) and commercial insurance or Medicaid, focusing on how these differ between patients in clinical trials and those who receive treatment post approval.
Read More
Drug Prices and OOP Costs Increased Beyond Inflation Rates 2009-2018, But Were Not Related
January 31st 2024Drug prices in the US increased 4.4% annually and median out-of-pocket (OOP) costs increased 9.6% annually from 2009 to 2018, but there was no direct link between these amounts for individual drugs.
Read More
What We’re Reading: Sickle Cell Treatment Access; Patent Thicket Attacks; US Syphilis Cases Rise
January 31st 2024Sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT) Access Model; the FTC has challenged the validity of over 100 drug product patents to help increase competition and potentially lower prices; the rate of infectious syphilis cases in the US rose 9% in 2022.
Read More
What We’re Reading: ADHD Medication Mix-Up; Surge in ACOs; Mifepristone Restrictions
January 30th 2024Attention-deficit/hyperactivity disorder (ADHD) medication packets are found with incorrect pills; CMS data reveal record numbers of providers and beneficiaries participating in accountable care organizations (ACOs); Supreme Court will hear arguments over FDA regulations on abortion medication in March.
Read More
Navigating Single Motherhood, Mental Health, and Finding Support Amidst Challenges
January 30th 2024UPMC Health Plan member Marjorie Robinson, of Monroeville, Pennsylvania, tells of her experiences with Pittsburgh-based Fabric Health as a single mom of 2 teenagers and why she believes that mental health–related concerns can be significant obstacles to overall good health.
Watch
Housing Stability and Adequate Health Care Are Crucial for Mental and Physical Health
January 28th 2024Serena Sloane, a Pittsburgh-based certified nursing assistant, took advantage of a chance meeting at her laundromat with someone from Fabric Health to learn more about her options for bettering her health care benefits
Watch
Health Equity and Access Weekly Roundup: January 27, 2024
January 27th 2024The Center on Health Equity and Access delivers current updates, highlights breakthroughs in research, and ongoing endeavors committed to addressing healthcare inequalities and improving universal access to exceptional health care.
Read More
US women in low-income regions are experiencing a steep increase in cervical cancer diagnosis and death despite medical improvements; a Senate committee launches an assisted living examination, its first hearing on the industry in 2 decades; the CDC urges health care providers to be alert for patients who have fever, rashes, an traveled abroad following reports of 23 measles cases since December 1.
Read More
Analysis Explores Gene Therapy’s Potential to Be Cost-Effective in SCD
January 22nd 2024This new economic valuation of the societal and health care benefits of gene therapy to treat sickle cell disease (SCD) concludes the highly personalized treatment has potential to be cost effective if priced below $2 million.
Read More
Study Highlights Treatment Patterns, Costs for DLBCL Not Treated With Stem Cell Transplant
January 19th 2024Most patients in the cohort received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for first-line therapy; hospitalization was prevalent; and average medical and pharmacy costs were more than $140,000 per patient per year.
Read More
New Study Series Addresses Racial Inequities in Pediatric Care, Need for Policy Reform
January 17th 2024The findings demonstrate the critical need for immediate policy reforms to tackle structural racism and promote equitable pediatric care in the US for children regardless of race or ethnicity.
Read More
What We’re Reading: Health Insurance Premiums; Drug Price Hikes; Postpartum Depression Pill Access
January 17th 2024Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill.
Read More
What We’re Reading: Saving Rural Hospitals; Rising Drug Prices; Global Tobacco Use Declines
January 16th 2024New program seeks to revitalize struggling rural health care facilities; NIH director advocates for actions to address unaffordable medications; WHO reveals significant drop global tobacco use
Read More
Navigating the Biosimilar Frontier: Opportunities and Challenges in 2024
January 14th 2024Biosimilars offer substantial promise for a new era of accessibility and affordability for patients and the broader health care industry, but better understanding of these products from payers and providers is necessary for biosimilars to reach their full potential in the US.
Read More
Health Equity and Access Weekly Roundup: January 13, 2024
January 13th 2024The Center on Health Equity and Access provides up-to-date news, showcases research advancements, and ongoing initiatives dedicated to tackling healthcare disparities and enhancing overall accessibility to outstanding care.
Read More
Fabric Health: Navigating Complex Health Care Systems Through Community Engagement
January 10th 2024A social-impact startup, Pittsburgh-based Fabric Health is adept at using community engagement to help members and their families navigate the complex world of health care—meeting customers where they are at, knowing time is often their most valuable resource.
Watch
Breaking Barriers in Bleeding Disorders: Experts Call for More Data on Women
January 8th 2024“These autosomal diseases, from an inheritance standpoint, affect men and women equally, but because of their impact on the gynecological system and menses, women are often affected much more than men," hematologist Donna DiMichele, MD, explains.
Read More